Paula González

发表

Genetic Admixture and Population Substructure in Guanacaste Costa Rica

S. Chanock, G. Thomas, Zhaoming Wang, 2010, PloS one.

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis

Chase W. Nelson, S. Franceschi, M. Yeager, 2017, Cell.

European Code against Cancer 4th Edition: Infections and Cancer.

S. Franceschi, J. Dillner, P. González, 2015, Cancer epidemiology.

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus

D. Lowy, S. Wacholder, M. Schiffman, 2014, BMC Infectious Diseases.

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

S. Chanock, M. Gail, D. Lowy, 2018, Vaccine.

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial

M. Gail, D. Lowy, W. Quint, 2018, Journal of the National Cancer Institute.

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

D. Lowy, C. Wheeler, S. Wacholder, 2015, The Lancet. Oncology.

Present status of human papillomavirus vaccine development and implementation.

P. González, R. Herrero, L. Markowitz, 2015, The Lancet. Oncology.

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

D. Lowy, S. Wacholder, M. Sherman, 2011, Journal of the National Cancer Institute.

Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trials.

C. Wheeler, M. Lehtinen, W. Quint, 2020, The Journal of infectious diseases.

Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials.

C. Wheeler, W. Quint, J. Sampson, 2019, Journal of the National Cancer Institute.

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

C. Wheeler, M. Lehtinen, D. Harper, 2017, Journal of the National Cancer Institute.

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.

D. Lowy, S. Wacholder, J. Palefsky, 2015, Vaccine.

Impact of human papillomavirus vaccination on cervical cytology screening, colposcopy, and treatment.

S. Wacholder, D. Solomon, A. Hildesheim, 2013, American Journal of Epidemiology.

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.

Diane Solomon, John Schiller, Allan Hildesheim, 2008, Vaccine.

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses

D. Lowy, S. Wacholder, W. Quint, 2013, Human vaccines & immunotherapeutics.

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

D. Lowy, S. Wacholder, W. Quint, 2013, Cancer Prevention Research.

Reproductive factors and molecular subtypes of breast cancer among premenopausal women in Latin America: the PRECAMA study

G. Bedoya, M. Olivier, P. Porter, 2018, Scientific Reports.

Epidemiology of Genital Chlamydia trachomatis Infection Among Young Women in Costa Rica

S. Wacholder, A. Hildesheim, A. Rodriguez, 2008, Sexually transmitted diseases.

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials

George Macones, Diane Solomon, Allan Hildesheim, 2010, BMJ : British Medical Journal.

Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods

Allan Hildesheim, Patti E. Gravitt, Hormuzd A. Katki, 2008, Journal of Clinical Microbiology.

Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.

Yurii B. Shvetsov, K. Robison, S. Franceschi, 2019, The Lancet. Infectious diseases.

The Natural History of Oral Human Papillomavirus in Young Costa Rican Women

W. Quint, J. Sampson, A. Hildesheim, 2017, Sexually transmitted diseases.

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

D. Lowy, S. Wacholder, W. Quint, 2013, PloS one.

Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.

S. Wacholder, M. Sherman, W. Quint, 2010, Journal of the National Cancer Institute.

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

D. Lowy, S. Wacholder, D. Solomon, 2007, JAMA.

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.

D. Lowy, S. Wacholder, W. Quint, 2011, The Lancet. Oncology.

Evaluation of a Novel PCR-Based Assay for Detection and Identification of Chlamydia trachomatis Serovars in Cervical Specimens

S. Wacholder, W. Quint, A. Hildesheim, 2007, Journal of Clinical Microbiology.

Evaluation of a Novel PCR-Based Assay for Detection and Identiﬁcation of Chlamydia trachomatis Serovars in Cervical Specimens (cid:1)

S. Wacholder, A. Hildesheim, A. Rodriguez, 2007 .

Establishment and Operation of a Biorepository for Molecular Epidemiologic Studies in Costa Rica

A. Hildesheim, A. Rodriguez, M. Schiffman, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.

S. Chanock, S. Wacholder, M. Sherman, 2009, The Journal of infectious diseases.

Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature

A. Giuliano, P. González, R. Herrero, 2010, Sexually transmitted diseases.

Anthropometry, body shape in early-life and risk of premenopausal breast cancer among Latin American women: results from the PRECAMA study

G. Bedoya, M. Olivier, P. Porter, 2020, Scientific Reports.

Cervicovaginal microbiome and natural history of HPV in a longitudinal study

P. Castle, R. Burk, M. Schiffman, 2020, PLoS pathogens.

HPV16 Seropositivity and Subsequent HPV16 Infection Risk in a Naturally Infected Population: Comparison of Serological Assays

S. Wacholder, W. Quint, A. Hildesheim, 2013, PloS one.

Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica

W. Quint, P. Castle, A. Hildesheim, 2007, Journal of Clinical Microbiology.

Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT).

D. Lowy, S. Wacholder, M. Sherman, 2020, The Journal of infectious diseases.

Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes

D. Lowy, M. Yeager, S. Wacholder, 2019, The Journal of infectious diseases.

Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure

L. Dodd, S. Wacholder, M. Sherman, 2011, Sexually transmitted diseases.

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

D. Lowy, S. Wacholder, J. Palefsky, 2022, Nature Communications.

Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial.

M. Gail, D. Lowy, W. Quint, 2020, Journal of the National Cancer Institute.

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

D. Lowy, S. Wacholder, A. Hildesheim, 2016, American journal of obstetrics and gynecology.

Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica.

D. Lowy, S. Wacholder, W. Quint, 2012, The Journal of infectious diseases.

Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study

M. Lehtinen, A. Hildesheim, M. Schiffman, 2021 .

Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study

G. Bedoya, G. Sánchez, P. Porter, 2022, BMC cancer.

Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica.

D. Lowy, S. Wacholder, W. Quint, 2013, The Journal of infectious diseases.

Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial.

S. Chanock, M. Gail, D. Lowy, 2020, Journal of the National Cancer Institute.

Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia

P. van Damme, P. González, R. Herrero, 2016, Cancer Prevention Research.

Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays

D. Lowy, S. Wacholder, A. Hildesheim, 2014, Front. Oncol..

Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment

M. Sherman, R. Burk, A. Hildesheim, 2012, International journal of cancer.

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.

D. Lowy, S. Wacholder, W. Quint, 2016, Journal of the National Cancer Institute.

A Comparison of Cervical and Vaginal Human Papillomavirus

P. Castle, R. Burk, A. Hildesheim, 2007, Sexually transmitted diseases.

Determinants of seropositivity among HPV-16/18 DNA positive young women

S. Wacholder, D. Solomon, A. Hildesheim, 2010, BMC infectious diseases.

Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.

S. Wacholder, M. Sherman, W. Quint, 2011, The Journal of infectious diseases.

Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay

D. Lowy, S. Wacholder, M. Pawlita, 2014, Human vaccines & immunotherapeutics.

Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile

F. Mégraud, P. González, R. Herrero, 2020, PloS one.

Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing.

S. Wacholder, W. Quint, A. Hildesheim, 2014, Journal of the National Cancer Institute.

Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years

S. Wacholder, R. Burk, A. Hildesheim, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.

Diane Solomon, Wim Quint, Allan Hildesheim, 2011, Cancer discovery.

Quantitative Detection and Genotyping of Helicobacter pylori from Stool using Droplet Digital PCR Reveals Variation in Bacterial Loads that Correlates with cagA Virulence Gene Carriage

F. Fang, A. Hildesheim, C. Porras, 2016, Helicobacter.

Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol

S. Tatti, E. Kasamatsu, A. Ferrera, 2020, BMJ Open.

Common Genetic Variation in TP53 and Risk of Human Papillomavirus Persistence and Progression to CIN3/Cancer Revisited

S. Chanock, M. Yeager, S. Wacholder, 2009, Cancer Epidemiology Biomarkers & Prevention.

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer

S. Chanock, S. Wacholder, Kai Yu, 2010, PloS one.

Seroprevalence and Correlates of Human Papillomavirus 16/18 Seropositivity Among Young Women in Costa Rica

S. Wacholder, M. Sherman, W. Quint, 2010, Sexually transmitted diseases.